1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Pompe Disease Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Pompe Disease Market Revenues & Volume, 2022 & 2032F |
3.3 Mexico Pompe Disease Market - Industry Life Cycle |
3.4 Mexico Pompe Disease Market - Porter's Five Forces |
3.5 Mexico Pompe Disease Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 Mexico Pompe Disease Market Revenues & Volume Share, By Treatment Type, 2022 & 2032F |
3.7 Mexico Pompe Disease Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Mexico Pompe Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of Pompe disease in Mexico |
4.2.2 Growing investments in research and development for Pompe disease treatments |
4.2.3 Favorable government policies and regulations supporting orphan drug development in Mexico |
4.3 Market Restraints |
4.3.1 High treatment costs associated with Pompe disease therapies |
4.3.2 Limited access to specialized healthcare facilities and expertise in managing Pompe disease in Mexico |
5 Mexico Pompe Disease Market Trends |
6 Mexico Pompe Disease Market, By Types |
6.1 Mexico Pompe Disease Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Mexico Pompe Disease Market Revenues & Volume, By Route of Administration, 2022-2032F |
6.1.3 Mexico Pompe Disease Market Revenues & Volume, By Oral, 2022-2032F |
6.1.4 Mexico Pompe Disease Market Revenues & Volume, By Parenteral, 2022-2032F |
6.2 Mexico Pompe Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Pompe Disease Market Revenues & Volume, By Substrate Reduction Therapy (SRT), 2022-2032F |
6.2.3 Mexico Pompe Disease Market Revenues & Volume, By Enzyme Replacement Therapy (ERT), 2022-2032F |
6.2.4 Mexico Pompe Disease Market Revenues & Volume, By Others, 2022-2032F |
6.3 Mexico Pompe Disease Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Pompe Disease Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.3 Mexico Pompe Disease Market Revenues & Volume, By Ambulatory Surgery Centers, 2022-2032F |
6.3.4 Mexico Pompe Disease Market Revenues & Volume, By Others, 2022-2032F |
7 Mexico Pompe Disease Market Import-Export Trade Statistics |
7.1 Mexico Pompe Disease Market Export to Major Countries |
7.2 Mexico Pompe Disease Market Imports from Major Countries |
8 Mexico Pompe Disease Market Key Performance Indicators |
8.1 Patient advocacy group engagement and support programs |
8.2 Number of clinical trials and research studies for Pompe disease in Mexico |
8.3 Availability and utilization of patient assistance programs for Pompe disease treatments |
9 Mexico Pompe Disease Market - Opportunity Assessment |
9.1 Mexico Pompe Disease Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 Mexico Pompe Disease Market Opportunity Assessment, By Treatment Type, 2022 & 2032F |
9.3 Mexico Pompe Disease Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Mexico Pompe Disease Market - Competitive Landscape |
10.1 Mexico Pompe Disease Market Revenue Share, By Companies, 2025 |
10.2 Mexico Pompe Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
